Market Access News | pharmaphorum

News

EMA starts review of 'transformative' bladder cancer therapy

The EMA has started a review of a regimen based on Pfizer/Astellas' Padcev and MSD's Keytruda that is described as a game-changer for bladder cancer.

News

Is FDA about to restrict vaccination even further?

Vinay Prasad, head of CBER, is reported to be planning to tighten regulations on vaccines after concluding that COVID-19 shots caused 10 child deaths.

News

Innovent gets OK for China's first home-grown IL-23p19 drug

Innovent has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for moderate-to-severe plaque psoriasis.

News

A person sat, bent over in the darkness of depression

Wellcome donates £2m to UK's digital mental health drive

Wellcome has provided £2m in additional funding to the MHRA and NICE for a project to build the use of digital mental health technologies in the NHS.

News

Novo Nordisk files Wegovy product that claimed rapid voucher

Novo Nordisk is using its recently awarded FDA priority voucher on a high-strength version of its obesity drug Wegovy.

News

Otsuka joins IgAN market with Voyxact approval in US

Otsuka has claimed FDA approval for its IgAN therapy Voyxact, joining an increasingly crowded market and beating rival Vera Therapeutics to the punch.

EMA starts review of 'transformative' bladder cancer therapy

Is FDA about to restrict vaccination even further?

Innovent gets OK for China's first home-grown IL-23p19 drug

Wellcome donates £2m to UK's digital mental health drive

Novo Nordisk files Wegovy product that claimed rapid voucher

Otsuka joins IgAN market with Voyxact approval in US

Recordati gets €10.9bn takeover bid from private equity firm

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks